Tryp Therapeutics Inc. (CSE: TRYP), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases with unmet medical...
Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being,...
LONDON, Sept. 19, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access...
Core One Labs Inc. (CSE:COOL | OTCQB:CLABF | Frankfurt:LD6, WKN:A3CSSU) is pleased to announce that following the receipt of very positive results during...
The article News You Might Have Missed: Sep 19th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly...
A jump in research studies sparks increased educational programs. The post The Future Psychedelics Workforce is Getting Schooled Today appeared first on...
Oral psilocybin film-strips to treat could conduct the first-in-human clinical study as soon as next year. The post Revive Therapeutics Gets Nod From FDA,...
TORONTO, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a...
The psychedelics industry is attracting more attention from less scrupulous operators who see the reward as worth the risk. The post Illicit Psychedelics...
Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely...